vs

Side-by-side financial comparison of Arcturus Therapeutics Holdings Inc. (ARCT) and MOVING iMAGE TECHNOLOGIES INC. (MITQ). Click either name above to swap in a different company.

Arcturus Therapeutics Holdings Inc. is the larger business by last-quarter revenue ($7.2M vs $3.8M, roughly 1.9× MOVING iMAGE TECHNOLOGIES INC.). On growth, MOVING iMAGE TECHNOLOGIES INC. posted the faster year-over-year revenue change (10.2% vs -68.4%). Over the past eight quarters, MOVING iMAGE TECHNOLOGIES INC.'s revenue compounded faster (7.8% CAGR vs -56.5%).

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

ARCT vs MITQ — Head-to-Head

Bigger by revenue
ARCT
ARCT
1.9× larger
ARCT
$7.2M
$3.8M
MITQ
Growing faster (revenue YoY)
MITQ
MITQ
+78.6% gap
MITQ
10.2%
-68.4%
ARCT
Faster 2-yr revenue CAGR
MITQ
MITQ
Annualised
MITQ
7.8%
-56.5%
ARCT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ARCT
ARCT
MITQ
MITQ
Revenue
$7.2M
$3.8M
Net Profit
$-388.0K
Gross Margin
30.7%
Operating Margin
-10.8%
Net Margin
-10.2%
Revenue YoY
-68.4%
10.2%
Net Profit YoY
3.1%
26.4%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARCT
ARCT
MITQ
MITQ
Q4 25
$7.2M
$3.8M
Q3 25
$17.2M
$5.6M
Q2 25
$28.3M
Q1 25
$29.4M
$3.6M
Q4 24
$22.8M
$3.4M
Q3 24
$41.7M
$5.3M
Q2 24
$49.9M
$6.3M
Q1 24
$38.0M
$3.9M
Net Profit
ARCT
ARCT
MITQ
MITQ
Q4 25
$-388.0K
Q3 25
$-13.4M
$509.0K
Q2 25
$-9.2M
Q1 25
$-14.1M
$-240.0K
Q4 24
$-30.0M
$-527.0K
Q3 24
$-6.9M
$-25.0K
Q2 24
$-17.2M
$-416.0K
Q1 24
$-26.8M
$-601.0K
Gross Margin
ARCT
ARCT
MITQ
MITQ
Q4 25
30.7%
Q3 25
30.0%
Q2 25
Q1 25
29.8%
Q4 24
27.2%
Q3 24
26.1%
Q2 24
22.5%
Q1 24
17.4%
Operating Margin
ARCT
ARCT
MITQ
MITQ
Q4 25
-10.8%
Q3 25
-96.3%
6.3%
Q2 25
-41.0%
Q1 25
-57.3%
-7.6%
Q4 24
-146.7%
-16.3%
Q3 24
-25.8%
-1.3%
Q2 24
-42.4%
-7.3%
Q1 24
-80.0%
-16.7%
Net Margin
ARCT
ARCT
MITQ
MITQ
Q4 25
-10.2%
Q3 25
-78.4%
9.1%
Q2 25
-32.4%
Q1 25
-47.9%
-6.7%
Q4 24
-131.8%
-15.3%
Q3 24
-16.6%
-0.5%
Q2 24
-34.5%
-6.6%
Q1 24
-70.5%
-15.4%
EPS (diluted)
ARCT
ARCT
MITQ
MITQ
Q4 25
$-0.04
Q3 25
$-0.49
$0.05
Q2 25
$-0.34
Q1 25
$-0.52
$-0.02
Q4 24
$-1.10
$-0.05
Q3 24
$-0.26
$0.00
Q2 24
$-0.64
$-0.04
Q1 24
$-1.00
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARCT
ARCT
MITQ
MITQ
Cash + ST InvestmentsLiquidity on hand
$230.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$214.0M
$5.0M
Total Assets
$271.1M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARCT
ARCT
MITQ
MITQ
Q4 25
$230.9M
Q3 25
$180.4M
Q2 25
$196.5M
Q1 25
$216.9M
Q4 24
$237.0M
Q3 24
$237.2M
Q2 24
$260.3M
Q1 24
$288.4M
Stockholders' Equity
ARCT
ARCT
MITQ
MITQ
Q4 25
$214.0M
$5.0M
Q3 25
$224.6M
$5.4M
Q2 25
$231.1M
Q1 25
$233.8M
$5.0M
Q4 24
$241.0M
$5.2M
Q3 24
$261.9M
$5.7M
Q2 24
$258.6M
$5.7M
Q1 24
$264.0M
$6.3M
Total Assets
ARCT
ARCT
MITQ
MITQ
Q4 25
$271.1M
$9.5M
Q3 25
$282.3M
$11.3M
Q2 25
$309.3M
Q1 25
$331.8M
$11.2M
Q4 24
$344.1M
$10.0M
Q3 24
$370.7M
$10.7M
Q2 24
$388.6M
$10.5M
Q1 24
$418.8M
$12.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARCT
ARCT
MITQ
MITQ
Operating Cash FlowLast quarter
$-74.3M
$-1.6M
Free Cash FlowOCF − Capex
$-74.5M
FCF MarginFCF / Revenue
-1035.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARCT
ARCT
MITQ
MITQ
Q4 25
$-74.3M
$-1.6M
Q3 25
$-17.2M
$-167.0K
Q2 25
$-5.8M
Q1 25
$-35.1M
$53.0K
Q4 24
$-284.0K
$70.0K
Q3 24
$-23.8M
$-32.0K
Q2 24
$-30.1M
$-472.0K
Q1 24
$-5.6M
$1.0M
Free Cash Flow
ARCT
ARCT
MITQ
MITQ
Q4 25
$-74.5M
Q3 25
$-17.3M
Q2 25
Q1 25
$-35.3M
Q4 24
Q3 24
$-23.8M
Q2 24
$-30.5M
Q1 24
$-5.8M
FCF Margin
ARCT
ARCT
MITQ
MITQ
Q4 25
-1035.2%
Q3 25
-101.1%
Q2 25
Q1 25
-120.1%
Q4 24
Q3 24
-57.2%
Q2 24
-61.1%
Q1 24
-15.3%
Capex Intensity
ARCT
ARCT
MITQ
MITQ
Q4 25
3.2%
Q3 25
1.1%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.7%
0.0%
Q1 24
0.6%
0.0%
Cash Conversion
ARCT
ARCT
MITQ
MITQ
Q4 25
Q3 25
-0.33×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons